PortfoliosLab logoPortfoliosLab logo
NEE vs. CRSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEE vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NextEra Energy, Inc. (NEE) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEE achieves a 8.63% return, which is significantly higher than CRSP's -5.03% return.


NEE

1D
1.36%
1M
-7.22%
YTD
8.63%
6M
6.81%
1Y
18.32%
3Y*
8.11%
5Y*
5.94%
10Y*
13.51%

CRSP

1D
-0.86%
1M
2.87%
YTD
-5.03%
6M
-12.14%
1Y
20.41%
3Y*
-6.43%
5Y*
-17.08%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEE vs. CRSP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEE
NextEra Energy, Inc.
8.63%15.47%21.46%-25.30%-8.54%23.39%30.06%42.69%14.30%34.39%
CRSP
CRISPR Therapeutics AG
-5.03%33.23%-37.12%54.00%-46.36%-50.51%151.39%113.18%21.68%15.89%

Correlation

The correlation between NEE and CRSP is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Oct 19, 2016

0.13

The correlation between NEE and CRSP shifts across timeframes, from 0.06 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

NEE:

$5.27

CRSP:

-$6.24

PS Ratio

NEE:

4.78

CRSP:

1.11K

Total Revenue (TTM)

NEE:

$27.93B

CRSP:

$4.10M

Gross Profit (TTM)

NEE:

$13.35B

CRSP:

-$171.17M

EBITDA (TTM)

NEE:

$14.56B

CRSP:

-$509.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEE vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEE
NEE Risk / Return Rank: 6868
Overall Rank
NEE Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
NEE Sortino Ratio Rank: 6363
Sortino Ratio Rank
NEE Omega Ratio Rank: 6363
Omega Ratio Rank
NEE Calmar Ratio Rank: 6969
Calmar Ratio Rank
NEE Martin Ratio Rank: 7373
Martin Ratio Rank

CRSP
CRSP Risk / Return Rank: 5454
Overall Rank
CRSP Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
CRSP Sortino Ratio Rank: 5555
Sortino Ratio Rank
CRSP Omega Ratio Rank: 5252
Omega Ratio Rank
CRSP Calmar Ratio Rank: 5454
Calmar Ratio Rank
CRSP Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEE vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NextEra Energy, Inc. (NEE) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NEECRSPDifference
Sharpe ratioReturn per unit of total volatility

+0.51

Sortino ratioReturn per unit of downside risk

+0.35

Omega ratioGain probability vs. loss probability

1.17

1.11

+0.06

Calmar ratioReturn relative to maximum drawdown

1.37

0.49

+0.88

Martin ratioReturn relative to average drawdown

3.78

0.81

+2.97

NEE vs. CRSP - Sharpe Ratio Comparison

The current NEE Sharpe Ratio is 0.84, which is higher than the CRSP Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of NEE and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NEE vs. CRSP - Drawdown Comparison

The maximum NEE drawdown since its inception was -47.81%, smaller than the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for NEE and CRSP.


Loading charts...

Drawdown Indicators


NEECRSPDifference

Max Drawdown

Largest peak-to-trough decline

-47.81%

-85.11%

+37.30%

Max Drawdown (1Y)

Largest decline over 1 year

-14.53%

-42.25%

+27.72%

Max Drawdown (3Y)

Largest decline over 3 years

-34.57%

-64.91%

+30.34%

Max Drawdown (5Y)

Largest decline over 5 years

-44.97%

-80.68%

+35.71%

Max Drawdown (10Y)

Largest decline over 10 years

-44.97%

Current Drawdown

Current decline from peak

-11.50%

-76.29%

+64.79%

Average Drawdown

Average peak-to-trough decline

-8.93%

-49.24%

+40.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.25%

25.51%

-20.26%

Volatility

NEE vs. CRSP - Volatility Comparison

The current volatility for NextEra Energy, Inc. (NEE) is 8.52%, while CRISPR Therapeutics AG (CRSP) has a volatility of 18.22%. This indicates that NEE experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEECRSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.52%

18.22%

-9.70%

Volatility (6M)

Calculated over the trailing 6-month period

16.75%

43.62%

-26.87%

Volatility (1Y)

Calculated over the trailing 1-year period

23.78%

62.44%

-38.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.91%

60.65%

-33.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.49%

64.35%

-38.86%

Dividends

NEE vs. CRSP - Dividend Comparison

NEE's dividend yield for the trailing twelve months is around 2.77%, while CRSP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CRSP
CRISPR Therapeutics AG
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NEE
NextEra Energy, Inc.
2.77%2.82%2.87%3.08%2.03%1.65%1.81%2.06%2.55%2.52%2.91%2.96%

Financials

NEE vs. CRSP - Financials Comparison

This section allows you to compare key financial metrics between NextEra Energy, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
6.70B
1.46M
(NEE) Total Revenue
(CRSP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NEE and CRSP have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRSP has higher volatility (18.22%) compared to NEE (8.52%). In terms of maximum drawdown, NEE dropped -47.81% vs CRSP's -85.11%.

NEE currently has the higher Sharpe Ratio (0.84 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEE and CRSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer